Clinical Trial Update: Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis [Phase 1, Phase 2]

View source ↗

Summary

Open-label PK and safety study of luliconazole 10% solution for distal subungual onychomycosis has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• luliconazole (luliconazole)

Snippet

Sponsor: Topica Pharmaceuticals | Conditions: Onychomycosis | Phase 1, Phase 2 | Status: COMPLETED